##  [Novartis Cosentyx receives FDA approval for treatment of children and adolescents with moderate to severe plaque psoriasis](/us-en/news/media-releases/novartis-cosentyx-receives-fda-approval-treatment-children-and-adolescents-moderate-severe-plaque-psoriasis-0 "Novartis Cosentyx receives FDA approval for treatment of children and adolescents with moderate to severe plaque psoriasis") 

  Jun 01, 2021